Background and Aims: Advanced breast cancer patients suffer from various psychological issues including depression and anxiety. This study aims to explore these psychological issues and their relationship with the performance status.Methods: This cross‐sectional study was conducted among 95 patients with metastatic breast cancer attending the Department of Palliative Medicine, Bangabandhu Sheikh Mujib Medical University, Bangladesh from April 2021 to September 2021. Data was collected by face‐to‐face interview using a structured questionnaire along with Hospital Depression and Anxiety Scale. The performance status of the patients was determined by the Eastern Cooperative Oncology Group (ECOG) performance scale. The association between different variables were assessed by χ2 test and Fisher Exact test.Result: Mean age of the respondents was 48.9 ± 9.9 years. Most of them were married (94.7%), muslim (92.6%) and homemakers (82.1%). More than half (52.6%) of the patients were evaluated having ECOG performance status grade II. Four out of ten (44.2%) patients had moderate to severely anxiety, and almost one‐third (36.9%) patients were suffering from moderate to severe depression. The patients with high educational status were found to have less depression. In addition, patients faring better on ECOG performance scale (Grade 0 to I) had significantly (p < 0.05) less depression and anxiety.Conclusion: Depression and anxiety are one of the major psychological sufferings among the women with metastatic breast cancers. All women suffering from breast cancer should be routinely screened and assessed for phychological distress and ensure early intervention.
Intraperitoneal administration of depot corticosteroids following an initial paracentesis reduces ascitic fluid formation and extends the interval between subsequent paracentesis sessions. This approach may effectively manage recurrent malignant ascites and enhance patients' quality of life.
29 November 2023 in Journal of Current and Advance Medical Research
Background: Hepatic encephalopathy is the most common and debilitating complication among the patients with cirrhosis. Electrolyte derangement is greatly related to recurrence and outcome of patients hospitalized with hepatic encephalopathy. Objective: This study was aimed to find out the association between these two variables in our setting. Methodology: The study was a cross-sectional study and conducted among 100 patients admitted with hepatic encephalopathy. Diagnosis and staging of hepatic encephalopathy were done based on West Haven staging, and severity of liver cirrhosis by the MELD (Model for End-Stage Liver Disease) scoring, and the outcomes were determined by the condition of the patients during discharge. Baseline serum electrolyte level was done for all the study participants. Results: Among 100 patients, male-female ratio was 7:3 with an average (standard deviation) age 56.25(±14.8) years. Most common causes of hepatic encephalopathy were infection (40.0%), gastrointestinal bleeding (30.0%), electrolyte abnormality (30.0%). Outcomes of hepatic encephalopathy were complete recovery (75.0%), needed ICU admission (15.0%) and death (10.0%). This study found no co-relation between baseline electrolyte and complete recovery of these patients and no association with the outcome of the patients. Conclusion: Baseline serum electrolyte have no significant influence on recovery of the patients with hepatic encephalopathy with liver cirrhosis. Journal of Current and Advance Medical Research, January 2023;10(1):41-46